Investigational Drug Information for Alovudine
✉ Email this page to a colleague
What is the development status for investigational drug Alovudine?
Alovudine is an investigational drug.
There have been 8 clinical trials for Alovudine.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 8th 2015.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Immunologic Deficiency Syndromes. The leading clinical trial sponsors are National Cancer Institute (NCI), Lederle Laboratories, and Boehringer Ingelheim.
There are four hundred and twenty-six US patents protecting this investigational drug and seven international patents.
Summary for Alovudine
| US Patents | 426 |
| International Patents | 7,563 |
| US Patent Applications | 2,095 |
| WIPO Patent Applications | 922 |
| Japanese Patent Applications | 278 |
| Clinical Trial Progress | Phase 2 (2015-12-08) |
| Vendors | 64 |
Recent Clinical Trials for Alovudine
| Title | Sponsor | Phase |
|---|---|---|
| Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement | National Cancer Institute (NCI) | Phase 2 |
| Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy | National Cancer Institute (NCI) | Early Phase 1 |
Clinical Trial Summary for Alovudine
Top disease conditions for Alovudine
Top clinical trial sponsors for Alovudine
US Patents for Alovudine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Alovudine | ⤷ Try a Trial | Methods of treating inflammation associated airway diseases and viral infections | WASHINGTON STATE UNIVERSITY (Pullman, WA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX) | ⤷ Try a Trial |
| Alovudine | ⤷ Try a Trial | Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections | EMORY UNIVERSITY (Atlanta, GA) | ⤷ Try a Trial |
| Alovudine | ⤷ Try a Trial | Use of gelsolin to treat infections | The Brigham and Women's Hospital, Inc. (Boston, MA) | ⤷ Try a Trial |
| Alovudine | ⤷ Try a Trial | Pyrazolopyrimidine compounds | GLAXOSMITHKLINE LLC (Wilmington, DE) | ⤷ Try a Trial |
| Alovudine | ⤷ Try a Trial | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | YALE UNIVERSITY (New Haven, CT) | ⤷ Try a Trial |
| Alovudine | ⤷ Try a Trial | Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1',2':4,5]pyrazino[1,2-a][- 1,3]diazepines and methods for treating viral infections | GILEAD SCIENCES, INC. (Foster City, CA) | ⤷ Try a Trial |
| Alovudine | ⤷ Try a Trial | Use of solid carrier particles to improve the processability of a pharmaceutical agent | Gilead Sciences, Inc. (Foster City, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Alovudine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Alovudine | Australia | AU2013336491 | 1989-12-31 | ⤷ Try a Trial |
| Alovudine | Brazil | BR112015006558 | 1989-12-31 | ⤷ Try a Trial |
| Alovudine | Canada | CA2885763 | 1989-12-31 | ⤷ Try a Trial |
| Alovudine | China | CN104884063 | 1989-12-31 | ⤷ Try a Trial |
| Alovudine | European Patent Office | EP2911674 | 1989-12-31 | ⤷ Try a Trial |
| Alovudine | Japan | JP2015534973 | 1989-12-31 | ⤷ Try a Trial |
| Alovudine | South Korea | KR20150084772 | 1989-12-31 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
